Skip to main content
Caplight Logo









Ananda Pharma plc

Ananda Pharma plc

Private
LondonHealthcare & Life Scienceshttps://www.anandapharma.co.uk/

Last Round

VC Round

Dec 9, 2024

Est. Valuation

$1.46M

Total Funding Raised

$2.94M

Company Overview

Ananda Pharma plc operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a VC Round in December 2024.

Ananda Pharma plc is a biopharmaceutical company that develops cannabinoid-based medicines to treat complex, chronic inflammatory pain conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ananda Pharma plc Comparables

Compare Ananda Pharma plc with similar companies based on industry and business-model similarity.

Ananda Pharma plc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vertanical GmbH
78%
BRC Therapeutics
78%
Octavian Therapeutics
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ananda Pharma plc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 9, 2024
Follow-on OfferingSep 12, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 9, 2024

    $190K raised in a VC Round.

  • Sep 12, 2024

    $3M round led by Charles Morgan

Book a demo to see all signals

For institutional investors. Book with your work email.

Ananda Pharma plc Filings

Explore SEC and related filing metadata, where available.

Ananda Pharma plc filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ananda Pharma plc's valuation, stock price, and market status.

Is Ananda Pharma plc a public or private company?

Ananda Pharma plc is a private company.

What is the current stock price of Ananda Pharma plc?

Ananda Pharma plc is a private company, so its shares have no public market price. Caplight tracks Ananda Pharma plc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ananda Pharma plc worth (valuation)?

Ananda Pharma plc's valuation is estimated at $1.5M based on funding round data.

Can I buy Ananda Pharma plc stock?

Ananda Pharma plc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ananda Pharma plc's last funding round?

Ananda Pharma plc's most recent funding round was VC Round on December 9, 2024.

Who are the main investors in Ananda Pharma plc?

Investor information for Ananda Pharma plc is not publicly disclosed.

Will Ananda Pharma plc IPO soon?

No public IPO plans have been announced for Ananda Pharma plc.

How can I track Ananda Pharma plc secondary market activity?

Caplight tracks bids, offers, and trades in Ananda Pharma plc's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Year Founded2018
Last FundingDec 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?